Greater weight loss and higher income (type 2 diabetes only) were associated with lower discontinuation, while weight regain since discontinuation was associated with higher reinitiation
Patients must also consider the financial implications, as off-label use may not be NHS-funded, potentially incurring substantial private costs
Both medications can rarely cause pancreatitis or worsen gallbladder symptoms
Gough SC, Bode B, Woo V, et al
Its not yet approved, so the conversation with a doctor right now is about whats in the pipeline, whether current GLP-1 options are working, and whether to watch for survodutide trials to participate in, she said
Vel also says thats something to consider